September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Alternative packaging and in vivo mutation correction
Author Affiliations & Notes
  • Eric A Pierce
    Ocular Genomics Institute, Mass Eye and Ear, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Eric Pierce, Editas Medicine (C)
  • Footnotes
    Support  Broadnext10 Award
Investigative Ophthalmology & Visual Science September 2016, Vol.57, No Pagination Specified. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Eric A Pierce; Alternative packaging and in vivo mutation correction. Invest. Ophthalmol. Vis. Sci. 201657(12):.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Presentation Description : This presentation will discuss our efforts to use the CRIPSR/Cas9 system to achieve correction of mutations in vivo, and studies of different methods to deliver Cas9 and gRNAs to the retina, including protein transfection

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.